- Home
- RAND vs LVTX Comparison
RAND vs LVTX Comparison
Compare RAND & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- LVTX
- Stock Information
- Founded
- RAND 1969
- LVTX 2016
- Country
- RAND United States
- LVTX Netherlands
- Employees
- RAND N/A
- LVTX N/A
- Industry
- RAND Finance: Consumer Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- LVTX Health Care
- Exchange
- RAND Nasdaq
- LVTX Nasdaq
- Market Cap
- RAND 57.6M
- LVTX 33.9M
- IPO Year
- RAND N/A
- LVTX 2021
- Fundamental
- Price
- RAND $16.20
- LVTX $1.32
- Analyst Decision
- RAND
- LVTX Hold
- Analyst Count
- RAND 0
- LVTX 3
- Target Price
- RAND N/A
- LVTX $1.75
- AVG Volume (30 Days)
- RAND 4.5K
- LVTX 13.2K
- Earning Date
- RAND 08-05-2025
- LVTX 08-19-2025
- Dividend Yield
- RAND 10.31%
- LVTX N/A
- EPS Growth
- RAND 39.77
- LVTX N/A
- EPS
- RAND 3.12
- LVTX N/A
- Revenue
- RAND $8,499,970.00
- LVTX $4,990,000.00
- Revenue This Year
- RAND N/A
- LVTX N/A
- Revenue Next Year
- RAND N/A
- LVTX N/A
- P/E Ratio
- RAND $5.22
- LVTX N/A
- Revenue Growth
- RAND 12.52
- LVTX N/A
- 52 Week Low
- RAND $14.20
- LVTX $0.85
- 52 Week High
- RAND $31.89
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- RAND 53.88
- LVTX 52.46
- Support Level
- RAND $15.00
- LVTX $1.27
- Resistance Level
- RAND $16.55
- LVTX $1.38
- Average True Range (ATR)
- RAND 0.36
- LVTX 0.04
- MACD
- RAND 0.21
- LVTX -0.00
- Stochastic Oscillator
- RAND 77.42
- LVTX 44.64
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.